Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize s... read more Featured Products: More products

Download Mobile App




Simple Colorimetric Assay Determines Human Mercaptalbumin Concentration

By LabMedica International staff writers
Posted on 30 Jun 2022

Human serum albumin (HAS) can take on two forms, mercaptalbumin (HMA) or non-mercaptalbumin (HNA), depending on the redox status of its Cys34. The ratio of HMA and HNA is considered to be a novel biomarker of oxidative stress.

The majority of studies on the redox state of HSA utilize high performance liquid chromatography (HPLC). Several recent studies have also employed mass spectrometry, which yields a higher resolution, thus allowing for finer distinctions between molecular structures. A handful of studies have explored alternative approaches using simple dye-based assays.

Clinical Laboratorians at The University of Tokyo Hospital (Tokyo, Japan) collaborated with colleagues at Nitto Boseki Co. Ltd., (Kawasaki, Japan) measured the concentrations of HMA in serum samples from 36 healthy subjects based on absorption changes of Michler's Hydrol. Michler's Hydrol (4,4′-Bis(dimethylamino)benzhydrol) is a blue dye with a maximum absorption at 612 nm, and its absorption decreases when it reacts with a thiol group.

After processing the samples, the solution was incubated further at room temperature for 20 minutes and absorbance at 612 nm (A612) was measured by a 96-well plate Nivo 3F microplate reader (PerkinElmer, Waltham, MA, USA). To evaluate the performance of the assays, the correlation was determined by a linear regression between the HMA concentrations obtained by Michler's Hydrol assay and corresponding reference concentrations obtained by HPLC and Bromocresol purple (BCP) assays.

The scientists reported that HMA concentrations obtained by Michler's Hydrol assay were highly correlated (r2 = 0.97) with reference values obtained by HPLC (HMA %) and BCP assay (total albumin). The HNA% obtained by Michler's Hydrol and BCP assays combined also gave a good correlation (r2 = 0.96) and a small deviation (average 2.4%) with respect to HPLC as a reference method. The use of the HMA/HNA ratio, which is a function of oxidation of Cys34, is considered a potential biomarker to assess the severity of chronic diseases for which oxidative stress is a significant etiological manifestation.

The authors concluded that the concentrations of HMA in human serum can be measured by Michler's Hydrol assay, which is based on an approximation of HMA concentrations with Michler's Hydrol's colorimetric changes mainly due to thiols. The assay accuracy was significantly improved by pre-incubation of a subset of the samples with an alkylating agent (iodoacetamide) and subtracting their absorption from the absorption of corresponding samples without alkylation. Proportions of HMA and HNA were also obtained by combining Michler's Hydrol assay and the BCP assay (for total albumin concentration). The results correlated well with HPLC, which has been established as a standard method for HMA/HNA measurement. The study was published on June 8, 2022 in the journal Practical Laboratory Medicine.

Related Links:
The University of Tokyo Hospital
Nitto Boseki Co. Ltd
PerkinElmer

 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.